Virtual Medicinal Product (VMP)
-
Metolazone 5mg tablets
Name Details
Current Name
Metolazone 5mg tablets
|
Start Date
SOT
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Caution - AMP level prescribing advised
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C03BA08
BNF |
Current BNF
02020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02020100
|
Start Date
31-01-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
42213711000001103 |
01-09-2023 |
|
317965001 |
SOT |
31-08-2023 |
VMP Ingredients
VMP ingredients table
Metolazone |
Based on Ingredient Substance |
|
5 mg |
|
Name
Metolazone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
Parent Products
-
VTM
Metolazone
-
VMP
(Current) Metolazone 5mg tablets
Virtual Medicinal Product Pack (VMPP) Information